AIS
CRBP icon

Accurate Investment Solutions’s Corbus Pharmaceuticals CRBP Stock Holding History

Accurate Investment Solutions’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3
Closed -$1K – 81
2020
Q1 		$1K Hold
3
– – ﹤0.01% 403
2019
Q4 		$1K Hold
3
– – ﹤0.01% 404
2019
Q3 		$0 Hold
3
– – ﹤0.01% 368
2019
Q2 		$1K Hold
3
– – ﹤0.01% 363
2019
Q1 		$1K Buy
+3
New +$662 ﹤0.01% 334

Other funds holding CRBP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Accurate Investment Solutions's CRBP Position: Q2 2020 in Review

Accurate Investment Solutions sold out of Corbus Pharmaceuticals (CRBP) in Q2 2020, closing a stake of 3 shares — an estimated $1K sold.

Accurate Investment Solutions first reported a position in CRBP in Q1 2019 and held it in 5 quarters. The position peaked at $1K in Q1 2020. 140 funds tracked by Wall St. Rank hold CRBP as of Q2 2020.

  • Accurate Investment Solutions reported no remaining Corbus Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Accurate Investment Solutions sold 3 Corbus Pharmaceuticals shares in Q2 2020, an estimated $1K.
  • Accurate Investment Solutions first reported a position in Corbus Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • Accurate Investment Solutions's Corbus Pharmaceuticals position peaked at $1K in Q1 2020.
  • 140 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.